Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors : Iconaru L, Moreau M, Baleanu F, Kinnard V, Charles A, Mugisha A, Surquin M, Benoit F, Karmali R, Paesmans M, Body JJ, Bergmann P
Year : 2021
Journal : Osteoporos Int
Volume : 32
Pages : 1093-1101

Sepsis and Septic Shock Definitions in Patients With Cancer Admitted in ICU.

Authors : Nathan N, Sculier JP, Ameye L, Paesmans M, Grigoriu B, Meert AP
Year : 2021
Journal : J Intensive Care Med
Volume : 36
Pages : 255-261

Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.

Authors : Mané M, Benkhaled S, Dragan T, Paesmans M, Beauvois S, Lalami Y, Szturz P, Gaye PM, Vermorken JB, Van Gestel D
Year : 2021
Journal : Oncologist
Volume : 26
Pages : e130-e141

Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohort.

Authors : Cappelle SI, Moreau M, Karmali R, Iconaru L, Baleanu F, Kinnard V, Paesmans M, Rozenberg S, Rubinstein M, Surquin M, Blard PH, Chapurlat R, Body JJ, Bergmann P
Year : 2021
Journal : Bone
Volume : 143
Pages : 115613

Reply to S. A. Narod et al.

Authors : Azim HA Jr, Ameye L, Paesmans M, Lambertini M
Year : 2020
Journal : J Clin Oncol
Volume : 38
Pages : 4352-4354

Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> Mutations.

Authors : Lambertini M, Ameye L, Hamy AS, Zingarello A, Poorvu PD, Carrasco E, Grinshpun A, Han S, Rousset-Jablonski C, Ferrari A, Paluch-Shimon S, Cortesi L, Senechal C, Miolo G, Pogoda K, Pérez-Fidalgo JA, De Marchis L, Ponzone R, Livraghi L, Estevez-Diz MDP, Villarreal-Garza C, Dieci MV, Clatot F, Berlière M, Graffeo R, Teixeira L, Córdoba O, Sonnenblick A, Luna Pais H, Ignatiadis M, Paesmans M, Partridge AH, Caron O, Saule C, Del Mastro L, Peccatori FA, Azim HA Jr
Year : 2020
Journal : J Clin Oncol
Volume : 38
Pages : 3012-3023

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity.

Authors : Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A
Year : 2020
Journal : ESMO Open
Volume : 5

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.

Authors : Demols A, Borbath I, Van den Eynde M, Houbiers G, Peeters M, Marechal R, Delaunoit T, Goemine JC, Laurent S, Holbrechts S, Paesmans M, Van Laethem JL
Year : 2020
Journal : Ann Oncol
Volume : 31
Pages : 1169-1177

What is the validity of self-reported fractures?

Authors : Baleanu F, Moreau M, Kinnard V, Iconaru L, Karmali R, Paesmans M, Bergmann P, Body JJ
Year : 2020
Journal : Bone Rep
Volume : 12
Pages : 100256

Underevaluation of fractures by self-report: an analysis from the FRISBEE cohort.

Authors : Baleanu F, Moreau M, Kinnard V, Iconaru L, Karmali R, Rozenberg S, Rubinstein M, Paesmans M, Bergmann P, Body JJ
Year : 2020
Journal : Arch Osteoporos
Volume : 15
Pages : 61

Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer.

Authors : Genot-Klastersky MT, Paesmans M, Ameye L, Kayumba A, Beauvois S, Dragan T, Van Gestel D, Lalami Y, Klastersky J
Year : 2020
Journal : Support Care Cancer
Volume : 28
Pages : 3015-3022

Do recent immigrants have similar obstetrical care and perinatal complications as long-term residents? A retrospective exploratory cohort study in Brussels.

Authors : Paquier L, Barlow P, Paesmans M, Rozenberg S
Year : 2020
Journal : BMJ Open
Volume : 10
Pages : e029683

Osteoporosis treatment gap in a prospective cohort of volunteer women.

Authors : Iconaru L, Smeys C, Baleanu F, Kinnard V, Moreau M, Cappelle S, Surquin M, Rubinstein M, Rozenberg S, Paesmans M, Karmali R, Bergmann P, Body JJ
Year : 2020
Journal : Osteoporos Int
Volume : 31
Pages : 1377-1382

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT.

Authors : Kinnard V, Baleanu F, Iconaru L, Moreau M, Paesmans M, Body JJ, Bergmann P
Year : 2020
Journal : J Bone Miner Res
Volume : 35
Pages : 827-828

Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer.

Authors : Pondé N, Ameye L, Lambertini M, Paesmans M, Piccart-Gebhart M, de Azambuja E
Year : 2020
Journal : Eur J Cancer
Volume : 126
Pages : 65-73

Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI.

Authors : Drisis S, El Adoui M, Flamen P, Benjelloun M, de Wind R, Paesmans M, Ignatiadis M, Bali MA, Lemort M
Year : 2020
Journal : J Magn Reson Imaging
Volume : 51
Pages : 1403-1411

CANCER DU SEIN AVEC MÉTASTASE INHABITUELLE AU NIVEAU VÉSICAL : RAPPORT DE CAS ET REVUE SYSTÉMATIQUE DE LA LITTÉRATURE

Authors : Marcoux D, Ignatiadis M, Paesmans M, Awada A
Year : 2019
Journal : Rev Med Brux
Volume : 40(3)
Pages : 148-159

Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.

Authors : Dragan T, Beauvois S, Moreau M, Paesmans M, Vandekerkhove C, Cordier L, Van Gestel D
Year : 2019
Journal : Oral Oncol
Volume : 98
Pages : 132-140

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Authors : Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Year : 2019
Journal : JCI Insight
Volume : 5

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Authors : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Year : 2019
Journal : J Nucl Med
Volume : 60
Pages : 178-184